Tranexamic acid to reduce blood loss after C-section
Part of Women’s health & pregnancy clinical trials.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your ultrasound before delivery showed placenta previa (placenta edge close to the cervix)
- You will have a C-section before or during labor, at 32 weeks or later
- You have no certain past blood clot or serious heart/brain blood vessel problems
- You have no major bleeding or bleeding/clotting disorders, and no placenta accreta suspicion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
This study looks at how tranexamic acid, a medicine to reduce bleeding, is given to people who have heavy bleeding after a cesarean delivery. It may help doctors improve treatment for this condition.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial tests whether giving tranexamic acid during a C-section can reduce the risk of heavy bleeding after childbirth. It may help women who have certain risk factors for postpartum hemorrhage.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.